Results 91 to 100 of about 174,600,072 (276)

Recovery from higher brain dysfunction following traumatic brain injury

open access: yesJournal of Human Environmental Studies, 2004
In this paper, through neuro-psychological tests and social-behavior disorder assessments, the researchers attempted to discover factors of recovery from higher brain dysfunction brought about by traumatic brain injury.
Junko Abe, Yuri Nagano, Akiko Abe
doaj   +1 more source

Prodromal Lewy Body Disorder Features in REM Sleep Behavior Disorder With Biomarker‐Defined Synucleinopathy

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Isolated rapid eye movement sleep behavior disorder (iRBD) is a prodromal state for Lewy body disorders and exhibits biological heterogeneity that may influence clinical expression and progression. We examined clinical features in individuals with iRBD and biomarker‐defined synucleinopathy.
Daniel Weintraub   +24 more
wiley   +1 more source

Psychoactive Drugs and Alterations to Consciousness

open access: yes, 2009
Altered states of consciousness (ASC) are difficult to define and previous attempts to do so have not been widely adopted. This is a problem inherent in defining consciousness in general. Theories that link ASC to neural substrates, such as the transient
Dietrich A., A. Dietrich
core   +1 more source

Assess the level of consciousness in patients with disorders of consciousness by combining resting-state and auditory-evoked EEG

open access: yesFrontiers in Neuroscience
IntroductionElectroencephalography (EEG) can provide objective neural marker for assessing the level of consciousness of patients with disorders of consciousness (DoC), but current research mainly focuses on the EEG features of a single modality, such as
Wenjin Zhang   +16 more
doaj   +1 more source

Early Clinical, Imaging, and Pathological Characteristics of SRPK3/TTN‐Digenic Myopathy

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective SRPK3/TTN‐digenic myopathy was recently established as a skeletal muscle myopathy caused by digenic inheritance. This study characterizes the early clinical presentation of SRPK3/TTN‐digenic myopathy in one previously reported and seven newly identified pediatric patients.
Rotem Orbach   +23 more
wiley   +1 more source

Sertraline Treatment Can Mimic Niemann‐Pick Type C Biomarker Profile: A Diagnostic Pitfall

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Oxysterols (cholestane‐3β,5α,6β‐triol and 7‐ketocholesterol) and N‐palmitoyl‐O‐phosphocholineserine (PPCS) are sensitive biomarkers for Niemann‐Pick disease type C (NPC) screening. However, false‐positive results occur, with a biomarker profile suggestive of NPC despite the absence of pathogenic variants in genes involved in NPC or ...
Maria Makrygianni   +19 more
wiley   +1 more source

The transient hypofrontality theory of altered states of consciousness

open access: yes, 2018
Consciousness-altering behaviour is, to a first approximation, a universal phenomenon; practically all human societies have experimented with altered states of consciousness (ASCs) in some form.
Dietrich, Arne, Al-Shawaf, Laith
core  

Founding Editorial: Neuro‐Drug Discovery

open access: yes
Neuro-Drug Discovery, EarlyView.
Wenbin Li
wiley   +1 more source

Spatial and Volumetric Characteristics of Glioblastoma: Associations With Clinical Presentation and Survival

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective We aim to comprehensively analyze how regional tumor and edema characteristics are associated with clinical presentations and survival outcomes in a large cohort of glioblastoma patients. Methods Patients with IDH‐wildtype glioblastoma who received brain MRI from 2010 to 2023 were included.
Daniel J. Zhou   +16 more
wiley   +1 more source

Long‐Term Efficacy of Immunotherapy in Autoimmune Autonomic Ganglionopathy—A 10‐Year Follow Up Study

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Autoimmune autonomic ganglionopathy (AAG) is a rare but potentially treatable cause of severe autonomic failure. Evidence guiding long‐term immunotherapy, treatment sequencing, and residual autonomic impairment is limited. We evaluated long‐term treatment response, residual autonomic dysfunction, and relapse patterns in patients with
Giacomo Chiaro   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy